登录 查看组织和合同定价。
选择尺寸
关于此项目
经验公式(希尔记法):
C15H29NOSn
化学文摘社编号:
分子量:
358.11
NACRES:
NA.22
PubChem Substance ID:
UNSPSC Code:
12352103
MDL number:
InChI
1S/3C4H9.C3H2NO.Sn/c3*1-3-4-2;1-2-5-3-4-1;/h3*1,3-4H2,2H3;1-2H;
SMILES string
CCCC[Sn](CCCC)(CCCC)c1ncco1
InChI key
YOWGRWHKDCHINP-UHFFFAOYSA-N
refractive index
n20/D 1.4930 (lit.)
bp
108-110 °C/0.2 mmHg (lit.)
density
1.170 g/mL at 25 °C, 1.71 g/mL at 25 °C (lit.)
Quality Level
General description
2-(Tri-n-butylstannyl)oxazole is a synthetic building block used in Stille coupling reaction.
Application
2-(Tri-n-butylstannyl)oxazole can be used as a reactant to prepare:
- Heteroaromatic compounds via Stille-Migita cross-coupling reaction with (hetero)aryl halides using a palladium catalyst.
- Ethyl 2-[3-(1,3-oxazol-2-yl)-1H-indazol-1-yl]acetate by reacting with 3-iodoindazole in the presence of Pd(PPh3)4 as a catalyst.
signalword
Danger
Hazard Classifications
Acute Tox. 3 Oral - Acute Tox. 4 Dermal - Aquatic Acute 1 - Aquatic Chronic 1 - Eye Irrit. 2 - Repr. 1B - Skin Irrit. 2 - STOT RE 1
存储类别
6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
Eyeshields, Faceshields, Gloves, type ABEK (EN14387) respirator filter
Oliver Krebs et al.
Organic letters, 7(6), 1063-1066 (2005-03-12)
[structure: see text] A strategy for the synthesis of ajudazol A, an unusual, pharmacologically active metabolite from myxobacteria, based on the Stille cross-coupling of a 2-stannyl-oxazole with a vinyl iodide unit is described; the vinyl halide unit containing a (Z,Z)-diene
Efficient synthesis of new 3-heteroaryl-1-functionalized 1H-indazoles
Fraile A, et al.
Tetrahedron, 67(1), 100-105 (2011)
An Efficient Low-Temperature Stille-Migita Cross-Coupling Reaction for Heteroaromatic Compounds by Pd-PEPPSI-IPent
Dowlut M, et al.
Chemistry?A European Journal , 16(14), 4279-4283 (2010)
Jacob A Kaizerman et al.
Bioorganic & medicinal chemistry letters, 20(15), 4607-4610 (2010-07-03)
Pyridopyridazine antagonists of the hedgehog signaling pathway are described. Designed to optimize our previously described phthalazine smoothened antagonists, a representative compound eliminates a PXR liability while retaining potency and in vitro metabolic stability. Moreover, the compound has improved efficacy in
我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持

